Page 19 - Amnio Breathe Hensler BioLabs 2020
P. 19

invention belongs. Publications cited herein and the materials for which they are cited
               are specifically incorporated by reference.

               Those skilled in the art will recognize, or be able to ascertain using no more than routine
               experimentation, many equivalents to the specific embodiments of the invention
               described herein. Such equivalents are intended to be encompassed by the following
               claims.


               Claims


               1. A method of treating or preventing a lung disorder or injury in a human, horse, dog or
               cat comprising administering to the lung of the human, horse, dog or cat in need of
               treatment a sterile amniotic fluid, in an amount effective to treat, alleviate, or prevent
               one or more symptoms of the lung disorder or injury, wherein the amniotic fluid is devoid
               of amniotic cells, micronized membrane, and chorion particles.

               2. The method of claim 1 wherein the amniotic fluid is administered in a dosage unit
               between about 0.1 cc and about 10.0 cc.


               3. The method of claim 3 wherein the amniotic fluid is diluted with sterile water, saline or
               buffer.


               4. The method of claim 1 wherein the amniotic fluid is administered to the pulmonary or
               nasal system.


               5. The method of claim 1 wherein the amniotic fluid is administered in the form of
               aerosol or with a nebulizer.

               6. The method of claim 6 wherein the aerosol produces droplets having a size between
               about 1.5 and 5 microns.

               7. The method of claim 7 wherein at least 30% of the aerosol droplets have a size
               between 1.5 and 5 microns in diameter.


               8. The method of claim 6 wherein the amniotic fluid is administered via a nebulizer.

               9. The method of claim 1 wherein the amniotic fluid is administered in combination with
               one or more therapeutic, prophylactic or diagnostic agents.

               10. The method of claim 10 wherein the amniotic fluid is administered in combination
               with one or more agents selected from the group consisting of bronchodilators,
               corticosteroids, methylxanthines, phosphodiesterase-4 inhibitors, anti-angiogenesis
               agents, antimicrobial agents, antioxidants, anti-inflammatory agents, growth factors,
               immunosuppressant agents, anti-allergic agents, and combinations thereof.


                                                             15
   14   15   16   17   18   19   20   21   22   23